Prognostic Value of Cardiac Sympathetic Nerve Activity Evaluated by 123I-Metaiodobenzylguanidine Imaging in Patients with ST-Segment Elevation Myocardial Infarctio
Phase 4
- Conditions
- ST-segment elevation myocardial infarction
- Registration Number
- JPRN-UMIN000001380
- Lead Sponsor
- Kitakanto Cardiovascular Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) Hepatic failure 2) Svere renal failure 3) Active cancer 4) Severe heart failure requiring mechanical support (mechanical ventilation, intraaortic balloon pumping, left ventricular assist device, or cardiac resynchronization therapy) 5) Requiring heart transplantation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Major adverse cardiac events
- Secondary Outcome Measures
Name Time Method